Consumer Defensive
Live Price
Offline$8.52
+0.00% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Comvita Ltd. (CVT) is a Consumer Defensive stock with a market cap of $4.19B and listed on NZX. The stock last traded around $8.52. Baseline metrics include revenue growth of +21.5%, EPS growth of -5.0%, a dividend yield of 0.0%. What stands out right now is revenue +21.5%, EPS -5.0%, free cash flow -13.5% with operating margin -12.0% and ROIC -4.0%. Valuation sits in the middle of the pack at price/sales 6.6. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines CVT price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+21.5% vs +1.7% peer median
Operating Margin
Below sector median
-12.0% vs +6.6% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report came in below the EPS bar
2023 was reported on Aug 3, 2023 with an EPS surprise of -220.0%.
The operating picture looks softer than before
Revenue is at +21.5% and EPS is at -5.0%, with operating margin around -12.0%.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CVT
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CVT Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CVT and SPY.
Company Overview
Comvita Ltd.
NZX
Comvita Ltd. is a leading natural health company specializing in the production and distribution of Manuka honey and other health products derived from bees. Founded in 1974 and headquartered in New Zealand, Comvita is renowned for its commitment to sustainability and the preservation of natural resources, ensuring the highest standards of environmental stewardship in its operations. The company's product portfolio extends beyond Manuka honey to include a range of wellness products like propolis, fresh-picked olive leaf extracts, and medihoney product lines. Comvita serves a diverse market spanning health-conscious consumers, nutraceutical industries, and natural product retailers worldwide. Through investments in research and development, Comvita maintains a strong focus on innovation, continually enhancing the health benefits and quality of its offerings. The company has established a critical role in the global health and wellness market, leveraging its expertise in bee-based products to contribute significantly to this burgeoning sector. Its deep-rooted focus on quality and sustainability distinguishes Comvita as a leader in natural health solutions.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.